Please login to the form below

Not currently logged in


This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

During the trial, patients were randomised to receive either PT027 or albuterol rescue, in addition to their usually prescribed maintenance ICS, with or without additional controller medicines.

Latest news

More from news
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 23 partially matching documents found.

Subscribe to our email news alerts


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....